BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 15383523)

  • 1. TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation.
    He L; Grammer AC; Wu X; Lipsky PE
    J Biol Chem; 2004 Dec; 279(53):55855-65. PubMed ID: 15383523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation.
    Fotin-Mleczek M; Henkler F; Hausser A; Glauner H; Samel D; Graness A; Scheurich P; Mauri D; Wajant H
    J Biol Chem; 2004 Jan; 279(1):677-85. PubMed ID: 14557256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
    Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
    J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway.
    Morrison MD; Reiley W; Zhang M; Sun SC
    J Biol Chem; 2005 Mar; 280(11):10018-24. PubMed ID: 15644327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
    Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
    Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both amino- and carboxyl-terminal domains of TRAF3 negatively regulate NF-kappaB activation induced by OX40 signaling.
    Takaori-Kondo A; Hori T; Fukunaga K; Morita R; Kawamata S; Uchiyama T
    Biochem Biophys Res Commun; 2000 Jun; 272(3):856-63. PubMed ID: 10860842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling.
    Hostager BS; Haxhinasto SA; Rowland SL; Bishop GA
    J Biol Chem; 2003 Nov; 278(46):45382-90. PubMed ID: 12958312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.
    Wong BR; Josien R; Lee SY; Vologodskaia M; Steinman RM; Choi Y
    J Biol Chem; 1998 Oct; 273(43):28355-9. PubMed ID: 9774460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
    Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
    Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappaB activation.
    Kawamata S; Hori T; Imura A; Takaori-Kondo A; Uchiyama T
    J Biol Chem; 1998 Mar; 273(10):5808-14. PubMed ID: 9488716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40.
    Tsukamoto N; Kobayashi N; Azuma S; Yamamoto T; Inoue J
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1234-9. PubMed ID: 9990007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation.
    Lee HH; Dempsey PW; Parks TP; Zhu X; Baltimore D; Cheng G
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1421-6. PubMed ID: 9990039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
    Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
    Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3.
    Sandberg M; Hammerschmidt W; Sugden B
    J Virol; 1997 Jun; 71(6):4649-56. PubMed ID: 9151858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells.
    Davies CC; Mak TW; Young LS; Eliopoulos AG
    Mol Cell Biol; 2005 Nov; 25(22):9806-19. PubMed ID: 16260598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-kappaB activation.
    Henkler F; Baumann B; Fotin-Mleczek M; Weingärtner M; Schwenzer R; Peters N; Graness A; Wirth T; Scheurich P; Schmid JA; Wajant H
    J Biol Chem; 2003 Aug; 278(31):29216-30. PubMed ID: 12709429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-kappa B, AND CBF1.
    Mann J; Oakley F; Johnson PW; Mann DA
    J Biol Chem; 2002 May; 277(19):17125-38. PubMed ID: 11886848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins.
    Takeuchi M; Rothe M; Goeddel DV
    J Biol Chem; 1996 Aug; 271(33):19935-42. PubMed ID: 8702708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1.
    Graham JP; Moore CR; Bishop GA
    J Immunol; 2009 Sep; 183(5):2966-73. PubMed ID: 19667091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.